GBA1 and Parkinson disease: There are also reports of increased levels of GluCer and GluSph in brain regions (including the substantia nigra and hippocampus) from sporadic PD patients and during aging (61–63), but it should be noted that other groups have not shown GSL accumulation in brains from GBA1-associated PD.